CML, FightSMA Canada collaborate to find a cure for spinal muscular atrophy

CML HealthCare Income Fund (TSX: CLC.UN), (CML) of Mississauga, Ontario has partnered with FightSMA Canada, to help find a cure for Spinal Muscular Atrophy (SMA), the leading genetic cause of death among children under the age of two. The awareness of the devastating impacts of SMA is low among the general public. The new partnership will provide a greater voice in the efforts to raise funds and increase awareness of SMA in communities across Canada.

SMA refers to a group of diseases, which affects the motor neurons of the spinal cord and brain stem. The disease does not discriminate on the basis of gender or ethnicity.

"CML HealthCare is proud to be a partner in the fight against SMA," said Paul Bristow, President and Chief Executive Officer. "We take great pride in supporting research that gives those individuals with SMA a fighting chance."

"FightSMA is excited to formalize our partnership with CML Healthcare in our efforts to find a cure. We have worked with CML for over two years now and we have done great things together. We look forward to the future opportunities that this partnership will provide to raise money and awareness for all of the individuals and families affected by SMA" Said Tracy Lacey, President of FightSMA Canada.




The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
Specific SARS-CoV-2 genetic elements found in different insect species